May 16, 2025 10:25 AM EDT <a>News Briefing</a><h1>FDA lifts hold on Scynex­is tri­al; In­cyte’s Zynyz notch­es an­oth­er FDA ap­proval</h1><h3><a>ENDPOINTS</a></h3><p>Plus, news about vTv Ther­a­peu­tics, Dy­navax, Au­ra Bio­sciences and Ark­Bio:</p><p><b>FDA lifts hold on Scynex­is’ Phase 3 fun­gal in­fec­tion tri­al:</b> The agency 

FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval

The FDA has lifted the hold on Scynexis' Phase 3 trial for a fungal infection, while Incyte's Zynyz received another FDA approval.